Corbus Pharmaceuticals Files Prospectus for $300M Shelf Offering
Wednesday, 13 March 2024, 21:18
Corbus Pharmaceuticals
Corbus Pharmaceuticals has filed a prospectus for a proposed mixed shelf offering of up to $300M. This filing is not an offer to sell securities.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.